[[1] Halperin EC, Brady LW, Perez CA, et al. Perez & Brady’s Principles and Practice of Radiation Oncology. Wolters Kluwer Health; 2013.]Search in Google Scholar
[[2] Donaldson SS, Hudson MM, Lamborn KR, et al. VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin’s disease: results of a prospective clinical trial. J Clin Oncol. 2002;20(14):3081-3087.10.1200/JCO.2002.12.10112118021]Search in Google Scholar
[[3] Specht L, Yahalom J, Illidge T, et al. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG). Int J Radiat Oncol Biol Phys. 2014;89(4):854-862.10.1016/j.ijrobp.2013.05.00523790512]Search in Google Scholar
[[4] Aleman BM, van den Belt-Dusebout AW, Klokman WJ, et al. Long-term cause-specific mortality of patients treated for Hodgkin’s disease. J Clin Oncol. 2003;21(18):3431-3439.10.1200/JCO.2003.07.13112885835]Search in Google Scholar
[[5] Ng AK. Review of the cardiac long-term effects of therapy for Hodgkin lymphoma. Br J Haematol. 2011;154(1):23-31.10.1111/j.1365-2141.2011.08713.x21539537]Search in Google Scholar
[[6] Baker JE, Moulder JE, Hopewell JW. Radiation as a risk factor for cardiovascular disease. Antioxid Redox Signalg. 2011;15(7):1945-1956.10.1089/ars.2010.3742315911321091078]Search in Google Scholar
[[7] Emami B. Tolerance of normal tissue to therapeutic radiation. Rep Rradiother Oncol. 2013;1(1):123-127.]Search in Google Scholar
[[8] Gagliardi G, Constine LS, Moiseenko V, et al. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys. 2010;76(3):S77-S85.10.1016/j.ijrobp.2009.04.09320171522]Search in Google Scholar
[[9] Hahn E, Jiang H, Ng A, et al. Late Cardiac Toxicity After Mediastinal Radiation Therapy for Hodgkin Lymphoma: Contributions of Coronary Artery and Whole Heart Dose-Volume Variables to Risk Prediction. Int J Radiat Oncol Biol Phys. 2017;98(5):1116-1123.10.1016/j.ijrobp.2017.03.02628721895]Search in Google Scholar
[[10] Jakacki RI, Goldwein JW, Larsen RL, et al. Cardiac dysfunction following spinal irradiation during childhood. J Clin Oncol. 1993;11(6):1033-1038.10.1200/JCO.1993.11.6.10338501489]Search in Google Scholar
[[11] Tukenova M, Guibout C, Oberlin O, et al. Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol. 2010;28(8):1308-1315.10.1200/JCO.2008.20.226720142603]Search in Google Scholar
[[12] Hoppe R. Hodgkin’s disease: complications of therapy and excess mortality. Ann Oncol. 1997;8(suppl 1):S115-S118.10.1093/annonc/8.suppl_1.S115]Search in Google Scholar
[[13] Ng AK, Bernardo MP, Weller E, et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin’s disease treated at age 50 or younger. J Clin Oncol. 2002;20(8):2101-2108.10.1200/JCO.2002.08.02111956271]Search in Google Scholar
[[14] Swerdlow AJ, Higgins CD, Smith P, et al. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study. J Natl Cancer Inst. 2007;99(3):206-214.10.1093/jnci/djk02917284715]Search in Google Scholar
[[15] Paumier A, Ghalibafian M, Beaudre A, et al. Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2011;80(1):199-205.10.1016/j.ijrobp.2010.09.00721481723]Search in Google Scholar
[[16] Engert A, Pluetschow A, Eich HT, et al. Combined Modality Treatment of Two or Four Cycles of ABVD Followed by Involved Field Radiotherapy in the Treatment of Patients with Early Stage Hodgkin’s Lymphoma: Update Interim Analysis of the Randomised HD10 Study of the German Hodgkin Study Group (GHSG). Blood. 2005;106(11):2673.10.1182/blood.V106.11.2673.2673]Search in Google Scholar
[[17] Yahalom J, Mauch P. The involved field is back: issues in delineating the radiation field in Hodgkin’s disease. Ann Oncol. 2002;13(suppl 1):79-83.10.1093/annonc/13.S1.79]Search in Google Scholar
[[18] Hoskin P, Díez P, Williams M, et al. Recommendations for the use of radiotherapy in nodal lymphoma. Clin Oncol. 2013;25(1):49-58.10.1016/j.clon.2012.07.01122889569]Search in Google Scholar
[[19] Herst J, Crump M, Baldassarre F, et al. Management of Early-stage Hodgkin Lymphoma: A Practice Guideline. Clin Oncol. 2017;29(1):e5-e12.10.1016/j.clon.2016.09.00627697411]Search in Google Scholar
[[20] Campbell BA, Voss N, Pickles T, et al. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin’s lymphoma: a question of field size. J Clin Oncol. 2008;26(32):5170-5174.10.1200/JCO.2007.15.100118838714]Search in Google Scholar
[[21] Koh E-S, Tran TH, Heydarian M, et al. A comparison of mantle versus involved-field radiotherapy for Hodgkin’s lymphoma: reduction in normal tissue dose and second cancer risk. Radiat Oncol. 2007;2:13.10.1186/1748-717X-2-13184751717362522]Search in Google Scholar
[[22] Koeck J, Abo-Madyan Y, Lohr F, et al. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy. Int J Radiat Oncol Biol Phys. 2012;83(1):268-276.10.1016/j.ijrobp.2011.05.05422079733]Search in Google Scholar
[[23] Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours. Wiley; 2011.10.1002/9780471420194.tnmc26.pub2]Search in Google Scholar
[[24] Khan FM, Gibbons JP. Khan’s The Physics of Radiation Therapy. Wolters Kluwer Health; 2014.]Search in Google Scholar
[[25] Barrett A, Dobbs J, Roques T. Practical Radiotherapy Planning Fourth Edition. Taylor & Francis; 2009.10.1201/b13373]Search in Google Scholar
[[26] Carr ZA, Land CE, Kleinerman RA, et al. Coronary heart disease after radiotherapy for peptic ulcer disease. Int J Radiat Oncol Biol Phys. 2005;61(3):842-850.10.1016/j.ijrobp.2004.07.70815708264]Search in Google Scholar
[[27] van Nimwegen FA, Schaapveld M, Cutter DJ, et al. Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma. J Clin Oncol. 2015;34(3):235-243.10.1200/JCO.2015.63.444426573075]Search in Google Scholar